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(VVB) in liver transplantation (LT): A randomized study. 
Preliminary results. Liver Transplantation and Surgery 1995; 1: 
415 (abstract).
Sir,—We appreciate the letter of Camprubi and Sabate which 
relates to our recent article on mucosal pH (pH,) during 
orthotopic liver transplantation (OLT)1. Their preliminary data 
suggest that the use of venovenous bypass (W B ) during the anhe- 
patic stage of OLT may indeed be beneficial for mucosal oxygen­
ation: in contrast with our results, gastric pH, was preserved with 
VVB, but decreased transiently without VVB. As pointed out in 
our article, we were unable to strictly test the hypothesis that W B  
would maintain mucosal blood flow as VVB was used routinely at 
our institution. Therefore, we cannot exclude the possibility that 
pH,- values might have decreased to even lower values without; 
VVB. 'lite main purpose of our study was to assess the ability of 
tonometry to detect intraoperative mucosal hypoxia, to measure 
gastric and sigmoid pH,-, and to relate the observed changes in pH 
to the occurrence of endotoxaemia and primary graft function.
Although in the preliminary report of Camprubi and colleagues, 
important information on patient physical status and determi-
i*
nants of tissue oxygenation is lacking, the fact that cardiac index, 
oxygen extraction and lactate concentration are comparable with 
the values measured in our study suggests that the different results 
for gastric pH, during the anhepatic stage may be attributed to the 
more severe chronic impairment of intestinal perfusion in our 
patients with end-stage cirrhosis. This is supported by the lower 
pH, values measured early during hepatectomy in our study (7.28 
vs 7.39). In fact, low pH, values (<7.32) have been reported in 
patients with chronic intestinal ischaemia and portal vein obstruc­
tion2. In agreement with our data, the pH,- values of Camprubi and 
colleagues’ patients without W B  had returned to baseline after 
reperfusion. However, in our patients with end-stage hepatic 
cirrhosis, pH,- did not reach normal values (>7.32) before the sec­
ond postoperative day, an observation that further supports the 
presence of chronic impairment of mucosal microcirculatory per­
fusion. Hence, pre-existing chronic mucosal hypoxia might explain 
why pH,- decreased during the anhepatic stage, although overall 
portal flow was maintained by the use of VVB.
It also cannot be excluded that the apparent difference in base­
line pH, values between our study and that of Camprubi and col­
leagues is a result of the use of different blood-gas analysers. 
Riddington and colleagues’ and Takala and colleagues'1 have 
shown that direct comparison of pH, values obtained by different 
analysers is not valid. Therefore, it was recommended that each 
institution should determine its own reference values for pH,-.
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Volatile anaesthetics and neuromuscular block
Sir,—I read with interest the article by Dr Vanlinthout and 
co-workers' and agree that the magnitude of potentiation of the 
effects of neuromuscular blocking agents by volatile anaesthesia is 
an important clinical question. We established recently that the 
dose of vecuronium required for a given effect during desfiurane 
anaesthesia was 20% less than that required during isofiurane 
anaesthesia2. Consequent from this small reduction in vecuronium 
dose requirements there was a much greater degree of recovery 
from the neuromuscular blocking agent when the concentration of
desfiurane was reduced compared with equivalent reductions in 
isofiurane. Hence, even small differences in potentiation can be of 
great clinical significance if neuromuscular blockers are adminis­
tered in response to monitoring (thereby taking advantage of 
reductions in dose requirements).
Dr Vanlinhout’s group set out to clarify inconsistencies in the 
literature on the interaction between sevoflurane and neuromus­
cular blocking agents. Unfortunately their study merely adds to 
the confusion. They concluded that sevoflurane and isofiurane 
potentiated neuromuscular blocking drugs to a similar degree. It is 
not reasonable to draw such a conclusion from the data presented 
in their article.
For vecuronium alone, they found an RDS0 value of 16.9 |ig kg '. 
With the degree of variability reported attd assuming that a 20% 
reduction in dose requirements is clinically relevant2, their study 
had, at best, only an 11% chance of demonstrating such a reduc­
tion. That is, if the reduction in vecuronium dose reported in the 
presence of sevoflurane (ED50 o f 14.4 |.ig kg"1, 17% less than with 
isofiurane) was a real (rather than chance) occurrence, then 204 
patients would have to have received each anaesthetic to have an 
80% chance of demonstrating such a difference at the 0.05 signifi­
cance level.
We should interpret their study with caution, l i t e  results of their 
study are entirely in keeping with there being a clinically important 
difference in the degree of neuromuscular blocker potentiation 
manifest by sevoflurane and isofiurane.
P. M . C . W right
Department of Anaesthesia 
University of Newcastle upon Tyne
1. Vanlinthout LE, Booij LD, Van Egmond J, Robertson EN. 
Effect of isofiurane and sevoflurane on the magnitude and 
time course of neuromuscular block produced by vecuro­
nium, pancuronium, and atracurium. British Journal of Anaes­
thesia 1996; 76: 389-395.
2. Wright PM, Hart P, Lau M, Brown R, Sharma ML, Gruenke 
L, Fisher DM. The magnitude and time course of vecuronium 
potentiation by desfiurane versus isofiurane. Anesthesiology 
1995;82:404-411.
Sir.,—Clinical interaction studies evaluating the influence of 
different anaesthetic techniques on the action of neuromuscular 
blocking agents often compare two or more groups of patients 
treated separately but concurrently as part of the same study. 
These studies are termed “parallel” to emphasize their difference 
from other clinical studies in which patients are their own controls. 
Parallel comparisons include most of the usual forms of 
interaction studies investigating the abilities of different inhalation 
anaesthetics to potentiate the neuromuscular effects of neuromus­
cular blocking agents. However, the large between-patient 
variability in dose-response and dose-duration studies with
neuromuscular blocking agents may preclude demonstration of 
subtle differences in susceptibility to these agents. Paired crossover 
studies can minimize the effect of inter-individual variability1. 
However, these paired crossover studies are difficult to perform 
with surgical patients. Healthy ASA I or II patients that are anaes-
« «
nitrous
two or more times, receiving on each occasion a 
anaesthetic technique, are rare. Therefore, these paired crossover 
studies have to be performed with volunteers.
Our clinical study was designed as a parallel comparison of dif­
ferent anaesthetic techniques, that is opioid-nitrous oxide-oxygen,
; -oxygen-isofiurane and opioid-nitrous 
oxide-oxygen-sevofiurane, in their ability to potentiate the 
neuromuscular effects of the most commonly used non­
depolarizing neuromuscular blocking agents in surgical patients. 
Using one-way analysis of variance (ANOVA) and subsequently 
the R yan-EinotGabriel-Welsh (REGW) multiple range test2 to 
■identify eventual sources of difference, there was a significant dif­
ference in magnitude and duration of neuromuscular action 
between the-control group, receiving no volatile agent, and the 
groups receiving inhalation anaesthetics. We were unable to dem­
onstrate any significant difference between opioid-nitrous oxide- 
oxygen-isollurane and opioid-nitrous oxide-oxygen-sevoflurane 
anaesthesia on the effects of neuromuscular blocking agents. In the 
population investigated, the differences between opioid-nitrous 
oxide-oxygen-isoflurane and opioid-nitrous oxide-oxygen- 
sevoflurane anaesthesia on the magnitude and duration of 
neuromuscular blocking agents were small compared with the 
between-patient differences in these responses to neuromuscular 
blocking agents (< 10% for the mean values of both magnitude and 
duration of action). In order to demonstrate significant differences
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in the potentiating abilities of isofiurane and sevoflurane on the 
effects of neuromuscular blocking agents, that is a significant; dif­
ference in both depth and duration, sample sizes of several 
hundreds of patients per neuromuscular blocking group would 
have been required*. Such sample sizes are beyond practicable 
limits. We selected our population carefully, using rigid inclusion 
criteria, as described in the text, to reduce patient variability. This 
inevitably introduced constraints such as the availability of large 
numbers of eligible patients within a reasonable period of time. 
Any investigator is limited by both resources and time. 
Additionally, our study was intended as a phase II trial to evaluate 
the interaction between sevoflurane and neuromuscular blocking 
agents within a limited number of surgical patients.
Both die investigator and clinician should be concerned about 
the ability to detect an important clinical difference. Different 
investigators disagree on what is a clinically significant difference. 
They also disagree on the risk they are willing to take of missing a 
meaningful effect caused by drug interaction'1. The choice of a 
20% difference in ED5t) as a clinically significant value is arbitrary. 
Such a difference is small compared with the large inter-individual 
differences in the response to neuromuscular blocking agents. 
With the degree of variability and sample sizes used in our study* a 
30% reduction in the EDgo of pancuronium and atracurium and a 
45% reduction in the E D 50 of vecuronium had an 80% chance of 
being significant at the 0.05 level.
Finally, we still feel that further interaction studies on the influ­
ence of higher concentrations of volatile anaesthetics on larger 
doses of neuromuscular blocking agents are warranted. To 
elucidate small but significant differences in the ability of 
isofiurane and sevoflurane to potentiate the action of neuromuscu­
lar blocking agents  ^these interaction studies need to be performed 
in volunteers who are studied twice, receiving isofiurane on one 
occasion and sevoflurane on the other5.L.E.H. V a n l in t h o u t
T. d e  B o o  L.H.DJ. B o o ij
Institute for Anaesthesiology 
University Hospital of Nijmegen 
Nijmegen, The Netherlands
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Cusum: a statistical m ethod to evaluate com petence in practical procedures
Sir,—It was interesting to read the commentary by Kestin1 
describing the use of cusum analysis to measure the competence of 
anaesthetic trainees at practical procedures. The cusum is a useful 
graphical tool for discerning trends from a series of observations. 
The derivation of boundary lines for sequential tests allows com­
parison of the observed proportions of success or failure against 
predetermined standard criteria. This could be developed into a 
continuous performance monitor in anaesthesia.
In his article, Kestin discussed the problems of keeping paper 
records and plotting fractions on the graphs. In response to this we 
set out to develop a computerized personal log book system for
procedures to run in parallel with the electronic
anaesthetic log book on the Psion 3a. However, in setting up the 
algorithms we have encountered a number of problems.
The values for s, hn and calculated using the formulae in the 
appendix do not agree with die values in table 1 of die article. On
reviewing the original articles’ on the application of the cusum, the 
value of Q  should read Q= Ln [ ( l-p 0) / ( l_/>i)]. The values in the 
table are indeed correct if this calculation is used for Q.
The null hypothesis in the article is stated as “the true failure 
rate is NOT different from the acceptable failure rate” and if the 
cusum exceeds /z, then it is rejected. This does not imply that the 
true failure rate exceeds the unacceptable failure rate which is the 
performance indicator which interests us. Similarly the alternative 
hypothesis is stated as “the true failure rate is equal to or exceeds 
die unacceptable failure rate” and if the cusum decreases to less 
than ha then it is accepted. Surely this would imply that the falling 
cusum of registrar B in figure 1 has a true failure rate that is equal 
to or exceeds the unacceptable failure rate.
p 0 corresponds to the failure rate under the null hypothesis 
which should surely read “the true failure rate is not different from 
the unacceptable failure rate”. If the cusum exceeds h¡ then this 
hypothesis is accepted and the trainee’s performance is unaccept­
able with reference to the agreed unacceptable failure rate. 
Similarly p¡ corresponds to the failure rate under the alternative 
hypothesis which should surely read “the true failure rate is equal 
to or exceeds the acceptable failure rate”. If the cusum decreases 
to less than h0 then the this hypothesis is rejected and the trainee’s 
performance is no worse than the accepted failure rate.
Furthermore, there appear to be clearcut criteria in the 
definition of success or failure for a particular procedure. This is 
confusing and it is difficult to see why type 1 and 2 errors of 10% 
(0.1) where chosen.
For reasons of convenience for the plotting of the graph, the val­
ues of s, h0 and hl where multiplied by 10. It is not clear if, in the 
event of a success, ( l - i ) ,  10 (1—i) or 1-1 Oí was plotted.
The statistical method described by Kestin appears to be a very 
powerful analytical tool and may have a wide range of applications 
in the assessment of trainees. However, the errors and inconsisten­
cies in the appendix are a source of confusion. It would be useful if 
the derivation of the definitions, variables, hypotheses and theory 
behind the calculations were explained more clearly.
E. J. H am m o n d
Department of Anaesthesia 
Poole General Hospital
A. K, M c In d o i;
Royal Devon and Exeter N H S Trust
1. Kestin IG. A statistical approach to measuring the compe­
tence of anaesthetic trainees at practical procedures. British 
Journal of Anaesthesia 1995; 75: 805-809.
2. Williams SM, Parry BR, Schlup MMT. Quality control: an 
application of the cusum. British Medical Journal 1992; 304: 
1359-1360.
Sir,—I would like to thank Drs Hammond and Mclndoe for their 
interest, and in particular for correcting the error in the formula 
for Q in the appendix-/),, and p x have been transposed.
In answer to their other comments, the advantages of using a  
and ß of equal magnitude is explained in the methods section; the 
choice of 0.1 was a compromise between the common values for u 
of 0.05 and for ß of 0.1 or 0.2 used in clinical studies. The software 
on the Psion 3a can be used to record and display the cusum; in
this case, it is not as helpful to have a  and ß equal than if graphical 
methods are used. The graphs used by our trainees were plotted 
using the nearest integers to 10j and 10 ( 1 —s') as the increments.
The original article in the British Medical Journal referred to by 
Drs Hammond and Mclndoe was the article that stimulated my 
interest in this topic. However, I found it difficult to understand 
the basic statistical concepts of cusum analysis from this article. I 
found it even more difficult to write an explanation myself, and 
this article is the only one of mine which the reviewers have ever 
suggested that more text be included to clarify the argument! I 
would refer them and others to Davies’ text1 for a better explana­
tion than I could provide. I. G. K f.s t in  
Department of A  naesthesia 
Derriford Hospital 
Plymouth
1. Davies OL. The Design and Analysis of Industrial Experiments, 
2nd Edn. London: Longman Group, 1978.
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(VVB) in liver transplantation (LT): A randomized study. 
Preliminary results. Liver Transplantation and Surgery 1995; 1: 
415 (abstract).
Sir,—We appreciate the letter of Camprubi and Sabate which 
relates to our recent article on mucosal pH (pH,) during 
orthotopic liver transplantation (OLT)1. Their preliminary data 
suggest that the use of venovenous bypass (W B ) during the anhe­
patic stage of OLT may indeed be beneficial for mucosal oxygen­
ation: in contrast with our results, gastric pH, was preserved with 
VVB, but decreased transiently without VVB. As pointed out in 
our article, we were unable to strictly test the hypothesis that W B  
would maintain mucosal blood flow as VVB was used routinely at 
our institution. Therefore, we cannot exclude the possibility that 
pH,- values might have decreased to even lower values without; 
VVB. 'lite main purpose of our study was to assess the ability of 
tonometry to detect intraoperative mucosal hypoxia, to measure 
gastric and sigmoid pH,-, and to relate the observed changes in pH 
to the occurrence of endotoxaemia and primary graft function.
Although in the preliminary report of Camprubi and colleagues, 
important information on patient physical status and determi-
i*
nants of tissue oxygenation is kicking, the fact that cardiac index, 
oxygen extraction and lactate concentration are comparable with 
the values measured in our study suggests that the different results 
for gastric pH, during the anhepatic stage may be attributed to the 
more severe chronic impairment of intestinal perfusion in our 
patients with end-stage cirrhosis. This is supported by the lower 
pH, values measured early during hepatectomy in our study (7.28 
vs 7.39). In fact, low pH, values (<7.32) have been reported in 
patients with chronic intestinal ischaemia and portal vein obstruc­
tion2. In agreement with our data, the pH,- values of Camprubi and 
colleagues’ patients without W B  had returned to baseline after 
reperfusion. However, in our patients with end-stage hepatic 
cirrhosis, pH,- did not reach normal values (>7.32) before the sec­
ond postoperative day, an observation that further supports the 
presence of chronic impairment of mucosal microcirculatory per­
fusion. Hence, pre-existing chronic mucosal hypoxia might explain 
why pH,- decreased during the anhepatic stage, although overall 
portal flow was maintained by the use of VVB.
It also cannot be excluded that the apparent difference in base­
line pH, values between our study and that of Camprubi and col­
leagues is a result of the use of different blood-gas analysers. 
Riddington and colleagues’ and Takala and colleagues'1 have 
shown that direct comparison of pH, values obtained by different 
analysers is not valid. Therefore, it was recommended that each 
institution should determine its own reference values for pH,-.
M . W elti;  
Institute of Anaes
»•shy
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1 Welte M, Pichler B, Groh J, Anthuber M, Jauch K-W, 
Pratschke E, Lenhart FP, Haller M, Frey L, Peter K. 
Perioperative mucosal pH and splanchnic endotoxin concen­
tration in orthotopic liver transplantation. British Journal of
Anaesthesia 1996; 76: 90..98.
Fiddian-Green RG, Stanley JC, Nostrant T,
Chronic gastric ischemia—A cause
s D.
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bleeding identified from the presence of gastric mucosal 
acidosis. Journal of Cardiovascular Surgery 1989; 30: 852 -859.
3. Riddington D, Venkatesch KB, Clutton-Brock T, Bion J. 
Measuring carbon dioxide tension in saline and alternative 
solutions: quantification of bias and precision in two blood gas 
analyzers. Critical Care Medicino 1994; 22: 96-100.
4. Takala J, Parviainen I, Siloaho M, Ruokonen E, Hämiiläincn 
E. Saline PCO-, is an important source of error in the assess­
ment of gastric intramucosal pH. Critical Care 
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Volatile anaesthetics and neuromuscular block
Sir,—I read with interest the article by Dr Vanlinthout and 
co-workers' and agree that the magnitude of potentiation of the 
effects of neuromuscular blocking agents by volatile anaesthesia is 
an important clinical question. We established recently that the 
dose of vecuronium required for a given effect during desfiurane 
anaesthesia was 20% less than that required during isofiurane 
anaesthesia2. Consequent from this small reduction in vecuronium 
dose requirements there was a much greater degree of recovery 
from the neuromuscular blocking agent when the concentration of
desfiurane was reduced compared with equivalent reductions in 
isofiurane. Hence, even small differences in potentiation can be of 
great clinical significance if neuromuscular blockers are adminis­
tered in response to monitoring (thereby taking advantage of 
reductions in dose requirements).
Dr Vanlinhout’s group set out to clarify inconsistencies in the 
literature on the interaction between sevoflurane and neuromus­
cular blocking agents. Unfortunately their study merely adds to 
the confusion. They concluded that sevoflurane and isofiurane 
potentiated neuromuscular blocking drugs to a similar degree. It is 
not reasonable to draw such a conclusion from the data presented 
in their article.
For vecuronium alone, they found an RDS0 value of 16.9 |ig kg '. 
With the degree of variability reported aitd assuming that a 20% 
reduction in dose requirements is clinically relevant2, their study 
had, at best, only an 11% chance of demonstrating such a reduc­
tion. That is, if the réduction in vecuronium dose reported in the 
presence of sevoflurane (ED50 o f 14.4 ng kg"1, 17% less than with 
isofiurane) was a real (rather than chance) occurrence, then 204 
patients would have to have received each anaesthetic to have an 
80% chance of demonstrating such a difference at the 0.05 signifi­
cance level.
We should interpret their study with caution, l i t e  results of their 
study are entirely in keeping with there being a clinically important 
difference in the degree of neuromuscular blocker potentiation 
manifest by sevoflurane and isofiurane.
P. M . C . W right
Department of Anaesthesia 
University of Newcastle upon Tyne
1. Vanlinthout LE, Booij LD, Van Egmond J, Robertson EN. 
Effect of isofiurane and sevoflurane on the magnitude and 
time course of neuromuscular block produced by vecuro­
nium, pancuronium, and atracurium. British Journal of Anaes­
thesia 1996; 76: 389-395.
2. Wright PM, Hart P, Lau M, Brown R, Sharma ML, Gruenke 
L, Fisher DM. The magnitude and time course of vecuronium 
potentiation by desfiurane versus isofiurane. Anesthesiology 
1995;82:404-411.
Sir,-—Clinical interaction studies evaluating the influence of 
different anaesthetic techniques on the action of neuromuscular 
blocking agents often compare two or more groups of patients 
treated separately but concurrently as part of the same study. 
These studies are termed “parallel” to emphasize their difference 
from other clinical studies in which patients are their own controls. 
Parallel comparisons include most of the usual forms of 
interaction studies investigating the abilities of different inhalation 
anaesthetics to potentiate the neuromuscular effects of neuromus­
cular blocking agents. However, the large between-patient 
variability in dose-response and dose-duration studies with
neuromuscular blocking agents may preclude demonstration of 
subtle differences in susceptibility to these agents. Paired crossover 
studies can minimize the effect of inter-individual variability1. 
However, these paired crossover studies are difficult to perform 
with surgical patients. Healthy ASA I or II patients that are anaes-
« «
nitrous
two or more times, receiving on each occasion a 
anaesthetic technique, are rare. Therefore, these paired crossover 
studies have to be performed with volunteers.
Our clinical study was designed as a parallel comparison of dif­
ferent anaesthetic techniques, that is opioid-nitrous oxide-oxygen,
; -oxygen-isofiurane and opioid-nitrous 
oxide-oxygen-sevofiuranc, in their ability to potentiate the 
neuromuscular effects of the most commonly used non­
depolarizing neuromuscular blocking agents in surgical patients. 
Using one-way analysis of variance (ANOVA) and subsequently 
the Ryan-EinotGabriel-Welsh (REGW) multiple range test2 to 
■identify eventual sources of difference, there was a significant dif­
ference in magnitude and duration of neuromuscular action 
between the-control group, receiving no volatile agent, and the 
groups receiving inhalation anaesthetics. We were unable to dem­
onstrate any significant difference between opioid-nitrous oxide- 
oxygen-isollurane and opioid-nitrous oxide-oxygen-sevoflurane 
anaesthesia on the effects of neuromuscular blocking agents. In the 
population investigated, the differences between opioid-nitrous 
oxide-oxygen-isoflurane and opioid-nitrous oxide-oxygen- 
sevoflurane anaesthesia on the magnitude and duration of 
neuromuscular blocking agents were small compared with the 
between-patient differences in these responses to neuromuscular 
blocking agents (< 10% for the mean values of both magnitude and 
duration of action). In order to demonstrate significant differences
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in the potentiating abilities of isofiurane and sevoflurane on the 
effects of neuromuscular blocking agents, that is a significant; dif­
ference in both depth and duration, sample sizes of several 
hundreds of patients per neuromuscular blocking group would 
have been required*. Such sample sizes are beyond practicable 
limits. We selected our population carefully, using rigid inclusion 
criteria, as described in the text, to reduce patient variability. This 
inevitably introduced constraints such as the availability of large 
numbers of eligible patients within a reasonable period of time. 
Any investigator is limited by both resources and time. 
Additionally, our study was intended as a phase II trial to evaluate 
the interaction between sevoflurane and neuromuscular blocking 
agents within a limited number of surgical patients.
Both die investigator and clinician should be concerned about 
the ability to detect an important clinical difference. Different 
investigators disagree on what is a clinically significant difference. 
They also disagree on the risk they are willing to take of missing a 
meaningful effect caused by drug interaction'1. The choice of a 
20% difference in ED5t) as a clinically significant value is arbitrary. 
Such a difference is small compared with the large inter-individual 
differences in the response to neuromuscular blocking agents. 
With the degree of variability and sample sizes used in our study* a 
30% reduction in the EDgo of pancuronium and atracurium and a 
45% reduction in the E D 50 of vecuronium had an 80% chance of 
being significant at the 0.05 level.
Finally, we still feel that further interaction studies on the influ­
ence of higher concentrations of volatile anaesthetics on larger 
doses of neuromuscular blocking agents are warranted. To 
elucidate small but significant differences in the ability of 
isofiurane and sevoflurane to potentiate the action of neuromuscu­
lar blocking agents  ^these interaction studies need to be performed 
in volunteers who are studied twice, receiving isofiurane on one 
occasion and sevoflurane on the other5.L.E.H. V a n l in t h o u tT. DE BooL.H.DJ. Booij
Institute for Anaesthesiology 
University Hospital of Nijmegen 
Nijmegen, The Netherlands
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Cusum: a statistical m ethod to evaluate com petence in practical procedures
Sir,—It was interesting to read the commentary by Kestin1 
describing the use of cusum analysis to measure the competence of 
anaesthetic trainees at practical procedures. The cusum is a useful 
graphical tool for discerning trends from a series of observations. 
The derivation of boundary lines for sequential tests allows com­
parison of the observed proportions of success or failure against 
predetermined standard criteria. This could be developed into a 
continuous performance monitor in anaesthesia.
In his article, Kestin discussed the problems of keeping paper 
records and plotting fractions on the graphs. In response to this we 
set out to develop a computerized personal log book system for
procedures to run in parallel with the electronic
anaesthetic log book on the Psion 3a. However, in setting up the 
algorithms we have encountered a number of problems.
The values for s, hn and calculated using the formulae in the 
appendix do not agree with die values in table 1 of die article. On
reviewing the original articles’ on the application of the cusum, the 
value of Q  should read Q= Ln [ ( l-p 0) / ( l_/>i)]. The values in the 
table are indeed correct if this calculation is used for Q.
The null hypothesis in the article is stated as “the true failure 
rate is NOT different from the acceptable failure rate” and if the 
cusum exceeds /z, then it is rejected. This does not imply that the 
true failure rate exceeds the unacceptable failure rate which is the 
performance indicator which interests us. Similarly the alternative 
hypothesis is stated as “the true failure rate is equal to or exceeds 
die unacceptable failure rate” and if the cusum decreases to less 
than ha then it is accepted. Surely this would imply that the falling 
cusum of registrar B in figure 1 has a true failure rate that is equal 
to or exceeds the unacceptable failure rate.
p 0 corresponds to the failure rate under the null hypothesis 
which should surely read “the true failure rate is not different from 
the unacceptable failure rate”. If the cusum exceeds h¡ then this 
hypothesis is accepted and the trainee’s performance is unaccept­
able with reference to the agreed unacceptable failure rate. 
Similarly p¡ corresponds to the failure rate under the alternative 
hypothesis which should surely read “the true failure rate is equal 
to or exceeds the acceptable failure rate”. If the cusum decreases 
to less than h0 then the this hypothesis is rejected and the trainee’s 
performance is no worse than the accepted failure rate.
Furthermore, there appear to be clearcut criteria in the 
definition of success or failure for a particular procedure. This is 
confusing and it is difficult to see why type 1 and 2 errors of 10% 
(0.1) where chosen.
For reasons of convenience for the plotting of the graph, the val­
ues of s, h0 and hl where multiplied by 10. It is not clear if, in the 
event of a success, ( l - i ) ,  10 (1 -i)  or 1-1 Oí was plotted.
The statistical method described by Kestin appears to be a very 
powerful analytical tool and may have a wide range of applications 
in the assessment of trainees. However, the errors and inconsisten­
cies in the appendix are a source of confusion. It would be useful if 
the derivation of the definitions, variables, hypotheses and theory 
behind the calculations were explained more clearly.
E. J. H am m o n d
Department of Anaesthesia 
Poole General Hospital
A. K, M c In d o i;
Royal Devon and Exeter N H S Trust
1. Kestin IG. A statistical approach to measuring the compe­
tence of anaesthetic trainees at practical procedures. British 
Journal of Anaesthesia 1995; 75: 805-809.
2. Williams SM, Parry BR, Schlup MMT. Quality control: an 
application of the cusum. British Medical Journal 1992; 304: 
1359-1360.
Sir,—I would like to thank Drs Hammond and Mclndoe for their 
interest, and in particular for correcting the error in the formula 
for Q in the appendix-/),, and p x have been transposed.
In answer to their other comments, the advantages of using a  
and ß of equal magnitude is explained in the methods section; the 
choice of 0.1 was a compromise between the common values for u 
of 0.05 and for ß of 0.1 or 0.2 used in clinical studies. The software 
on the Psion 3a can be used to record and display the cusum; in
this case, it is not as helpful to have a  and ß equal than if graphical 
methods are used. The graphs used by our trainees were plotted 
using the nearest integers to 10„v and 10 ( 1 —s') as the increments.
The original article in the British Medical Journal referred to by 
Drs Hammond and Mclndoe was the article that stimulated my 
interest in this topic. However, I found it difficult to understand 
the basic statistical concepts of cusum analysis from this article. I 
found it even more difficult to write an explanation myself, and 
this article is die only one of mine which the reviewers have ever 
suggested that more text be included to clarify the argument! I 
would refer them and others to Davies’ text1 for a better explana­
tion than I could provide. I. G. K f.s t in  
Department of A  naesthesia 
Derriford Hospital 
Plymouth
1. Davies OL. The Design and Analysis of Industrial Experiments, 
2nd Edn. London: Longman Group, 1978.
